With Academic Funding, GSK Looks to Zap Life Into Electroceuticals

By seeding exploratory lab work across several biomedical and engineering disciplines, GlaxoSmithKline wants to understand how neural signals regulate diseases and eventually to design devices that can alter signals and provide therapeutic benefit.